ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY...
Brain
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF),...
Generation Lab Raises $11M Seed Round as SystemAge™ Becomes World’s Fastest-Growing Longevity Diagnostic
Among the top 1% of startup raises, the round will accelerate adoption of the SystemAge breakthrough aging diagnostic platform across...
NEUROMARK® Now with Expanded Access on UnitedHealthcare’s Medicare Advantage Policy for Posterior Nasal Nerve Ablation
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, Oct....
Moberg Analytics Secures $600,000 to Accelerate Commercialization of Its Brain Monitoring Platform
PHILADELPHIA, Oct. 22, 2025 /PRNewswire/ -- Moberg Analytics, a pioneer in advanced brain monitoring and critical care informatics, today announced...
PureTalk Honors Veterans by Teaming Up with K9s For Warriors
Veteran-led wireless provider takes action to support heroes battling invisible wounds with life-saving service dogs COVINGTON, Ga., Oct. 22, 2025...
Sphere and The National Health Council Partner to Advance Responsible AI in Patient-Centered Healthcare
The partnership focuses on improving responsible AI use in healthcare for better decision-making and efficient operations, emphasizing patient needs and...
Canadian startup launches wearable to improve gait and reduce falls in older adults
MONTREAL, Oct. 22, 2025 /CNW/ - PhysioBiometrics Inc. has launched Heel2Toe™, a wearable therapeutic device designed to assess and train...
Clinical Study Reveals Cereset® BrainEcho™ Technology Delivers Real Solutions for Stress, Anxiety, and Sleeplessness
SCOTTSDALE, Ariz., Oct. 22, 2025 /PRNewswire/ -- A clinical study with 144 healthcare workers at Wake Forest School of Medicine...
Oticon introduces the world’s smallest powerhouse: Oticon Intent™ miniBTE R with two fitting levels
Building on the success of the world's first hearing aid with second-generation AI and user-intent sensors, Oticon introduces the Oticon...
Oticon announces a revolutionary new hearing aid style: Oticon Zeal™, the world’s most discreet, complete hearing aid
The completely new in-the-ear hearing aid style is the world's first solution where users don't need to compromise between in-the-ear...
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
ROCKVILLE, MD / ACCESS Newswire / October 21, 2025 / Radiation therapy has always been the heavyweight of cancer treatment....
BURL CONCEPTS CLOSES CURRENT OVERSUBSCRIBED $4.5 MILLION INVESTMENT
Funding to support launch of non-invasive SONAS® ultrasound system in the Patent Foramen Ovale (PFO) market SAN DIEGO, Oct. 21,...
Subtle Medical Announces Positive Findings from Proof-of-Concept Study with Bayer Investigating AI To Lower Gadolinium Dose in CE-MRI
MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ -- Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive...
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
Three Independent Studies Published in “Alzheimer’s Research & Therapy,” “Journal of Alzheimer’s Disease,” and “Radiology” Validate Nexalin’s Non-Invasive Approach with...
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
- Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT®, the innovative alpha-radiation cancer therapy...
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of...
Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis
INDIANAPOLIS, Oct. 20, 2025 /PRNewswire/ -- Plug and Play, the world's largest innovation platform, today announced the 12 companies selected...
Spring Health and Expert Council Release VERA-MH, the First Open-Source Evaluation for Validating AI in Mental Health
Developed in collaboration with a cross-disciplinary AI Council of technology, healthcare, and academic leaders, VERA-MH (Validation of Ethical and Responsible...
Kandu, Inc. Announces Expansion of Executive Leadership Team and Board of Directors
Nabeel Ahmed Named Chief Financial Officer; Mike Levitz and Bret Christensen Join Board of Directors LOS ANGELES, Oct. 20, 2025...